7467-42-7

Basic information

• Product Name: 4-aminobenzamidopyridine
• Synonyms: 4-aminobenzamidopyridine;4-Amino-N-(2-pyridinyl)benzamide;benzamide, 4-amino-N-2-pyridinyl-;4-AMino-N-(2-pyridyl)benzaMide;2-(p-Aminobenzamido)pyridine;2-(p-Amino-Benzamido)pyridine;Benzamide, 4-amino-N-2-pyridinyl- (9CI);Benzamide, p-amino-N-2-pyridinyl-
• CAS NO: 7467-42-7
• Molecular Formula: C₁₂H₁₁N₃O
• Molecular Weight: 213.24
• Mol File: 7467-42-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 342.9°C at 760 mmHg
• Flash Point: 161.2°C
• Appearance: /
• Vapor Pressure: 7.29E-05mmHg at 25°C
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-aminobenzamidopyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-aminobenzamidopyridine(7467-42-7)
• EPA Substance Registry System: 4-aminobenzamidopyridine(7467-42-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 7467-42-7(Hazardous Substances Data)

Usage

General Description

4-aminobenzamidopyridine is a chemical compound consisting of a benzene ring with an amino group and an amide group attached to it, as well as a pyridine ring. It is used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceuticals, particularly in the production of anti-inflammatory and analgesic drugs. Additionally, 4-aminobenzamidopyridine has been studied for its potential use in photodynamic therapy, which is a treatment that uses light and a photosensitizing chemical to kill cancer cells. The compound has also been researched for its potential anti-tumor properties and its ability to inhibit the growth of cancer cells. Overall, 4-aminobenzamidopyridine is a versatile and important chemical in the field of medicine and pharmaceuticals.

InChI:InChI=1/C12H11N3O.2ClH/c13-10-6-4-9(5-7-10)12(16)15-11-3-1-2-8-14-11;;/h1-8H,13H2,(H,14,15,16);2*1H

Upstream product

• 504-29-0 2-aminopyridine 
• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 
• 62-23-7 4-nitro-benzoic acid 
• 7498-40-0 4-nitro-N-pyridine-2-yl-benzamide 

Downstream Products

• 1261035-36-2 N-(pyridine-2-yl)-4-dodecanamido-benzamide 
• 1261035-37-3 N-(pyridin-2-yl)-4-stearamidobenzamide 
• 1372892-86-8 4-((3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)-N-(pyridin-2-yl)benzamide 

Relevant articles and documents

S-triazine compounds as well as preparation method and application thereof

The invention discloses s-triazine compounds and pharmaceutically acceptable salts thereof; experiments prove that the compounds can be used for treating or preventing diseases related to protein kinase activity, such as leukemia and lymphoma, by inhibiti

ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

The present invention relates to a compound of formula (I) wherein X1 represents an alkenylene group, a -NH-CO- group, a -CO-NH- group, Y1 represents an aryl group selected from a pyridyl group, a pyrazinyl group or a pyrimidinyl group, X2 represents a -O- group, a-CO-NH- group, a -NH-CO-NH- group, a -OCH2- group, a -NH-CO- group, a divalent 5-membered heteroaromatic ring comprising 1, 2, 3 or 4 heteroatoms or a -SO2-NH- group, and Y2 represents a hydrogen atom, a hydroxyl group, a morpholinyl group, a piperidinyl group, optionally substituted by a (C1-C4)alkyl group, a piperazinyl group, optionally substituted by a (C1-C4)alkyl group, or a -CR1R2R3 group or alternatively X2-Y2 represents a group -CONRcRd, wherein Rc and Rd form, together with the nitrogen atom a heterocyclic ring, optionally substituted by one or two (C1-C4)alkyl group, by a cyclopentyl group thus forming a spirocyclopentyl, or by a trifluoromethyl group, or any of its pharmaceutically acceptable salt, for use in the treatment and/or prevention of a RNA virus infection caused by a RNA virus belonging to group IV or V of the Baltimore classification. The present invention further relates to new compounds, to pharmaceutical compositions containing them and to synthesis process for manufacturing them.

PARA AMINO BENZOIC ACID BASED NANOTUBES

The invention relates to nanotubes and processes for making them and intermediates of a drug moiety or its derivative/s as a structural moiety with side chain/s capable of promoting self aggregation. The side chain/s are mono or a multiple of alkyl chain/